B Verve Therapeutics (VERV) acquisition offers investors a 70%+ premium. See why I think this deal is beneficial to both ...

Eli Lilly has agreed to acquire cardiovascular disease treatment specialist Verve Therapeutics in a deal potentially rising ...

Eli Lilly (NYSE:LLY) recently saw its stock price rise by 6.63% over the last month, a movement potentially influenced by ...

Deal would add a potential treatment for cardiovascular disease to Eli Lilly's portfolio. The food giant says it will remove the dyes from products including Jell-O, Kool-Aid and Crystal Light before ...

Verve Therapeutics is a clinical-stage company developing genetic medicines for cardiovascular disease, with its lead program ...

U.S. stocks are drifting lower, while oil prices are rising again. The S&P 500 fell 0.2% Tuesday. The Dow Jones Industrial ...

Verve Therapeutics soared 79% after Eli Lilly announced it would acquire the genetic medicine firm in a deal worth up to $1.3 billion, including milestone payments. Shares of Lilly dipped 1.3%.

US stocks open lower after Trump exits the G7 summit early because of Mideast tensions. No tade deals were struck. May retail sales drop. Fed meets.